Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review

By Meune C.   Mahe I.   Mourad J.J.   Simoneau G.   Knellwolf A.L.   Bergmann J.F.   Caulin C.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 609-620

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of Catechol-O-Methyltransferase

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 324-332

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 306-323

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite